Patrick Rosaire Bazinet is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of targeted drug delivery systems. With a total of 5 patents to his name, Bazinet's work focuses on improving the efficacy and safety of therapeutic agents.

Latest Patents

Among his latest patents, Bazinet has developed formulations involving targeted conjugates and particles. These nanoparticles and microparticles are designed to enhance the temporospatial delivery of active agents, such as therapeutic, prophylactic, or diagnostic agents. His innovative approach includes the use of a targeting moiety, such as a somatostatin receptor binding moiety, linked to the active agent. This technology aims to improve biodistribution and reduce toxicity, particularly in the treatment of cancer and infectious diseases. Another significant patent involves SSTR-targeted conjugates, which utilize DM1 attached to a targeting moiety, providing improved delivery and penetration in tumors.

Career Highlights

Throughout his career, Bazinet has worked with several companies, including Tarveda Therapeutics, Inc. and Tva (ABC), LLC. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that push the boundaries of pharmaceutical science.

Collaborations

Bazinet has collaborated with notable professionals in the field, including Mark T Bilodeau and Sudhakar Kadiyala. These partnerships have contributed to the advancement of his innovative work and the successful development of his patented technologies.

Conclusion

Patrick Rosaire Bazinet's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving patient outcomes. His work in targeted drug delivery systems is paving the way for more effective treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.